-
Je něco špatně v tomto záznamu ?
Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site
M. Vojsovič, L. Kratochvilová, N. Valková, L. Šislerová, Z. El Rashed, P. Menichini, A. Inga, P. Monti, V. Brázda
Jazyk angličtina Země Francie
Typ dokumentu časopisecké články
- MeSH
- aktivace transkripce MeSH
- DNA chemie MeSH
- G-kvadruplexy * MeSH
- mutantní proteiny genetika MeSH
- nádorový supresorový protein p53 * metabolismus MeSH
- Saccharomyces cerevisiae genetika metabolismus MeSH
- transkripční faktory metabolismus MeSH
- Publikační typ
- časopisecké články MeSH
The effect of mutations in the P53 family of transcription factors on their biological functions, including partial or complete loss of transcriptional activity, has been confirmed several times. At present, P53 family proteins showing partial loss of activity appear to be promising potential candidates for the development of novel therapeutic strategies which could restore their transcriptional activity. In this context, it is important to employ tools to precisely monitor their activity; in relation to this, non-canonical DNA secondary structures in promoters including G-quadruplexes (G4s) were shown to influence the activity of transcription factors. Here, we used a defined yeast assay to evaluate the impact of differently modeled G4 forming sequences on a panel of partial function P53 family mutant proteins. Specifically, a 22-mer G4 prone sequence (derived from the KSHV virus) and five derivatives that progressively mutate characteristic guanine stretches were placed upstream of a minimal promoter, adjacent to a P53 response element in otherwise isogenic yeast luciferase reporter strains. The transactivation ability of cancer-associated P53 (TA-P53α: A161T, R213L, N235S, V272L, R282W, R283C, R337C, R337H, and G360V) or Ectodermal Dyplasia syndromes-related P63 mutant proteins (ΔN-P63α: G134D, G134V and inR155) were tested. Our results show that the presence of G4 forming sequences can increase the transactivation ability of partial function P53 family proteins. These observations are pointing to the importance of DNA structural characteristics for accurate classification of P53 family proteins functionality in the context of the wide variety of TP53 and TP63 germline and somatic mutations.
Gene Expression Regulation IRCCS Ospedale Policlinico San Martino 16132 Genoa Italy
Institute of Biophysics of the Czech Academy of Sciences Královopolská 135 61200 Brno Czech Republic
Mutagenesis and Cancer Prevention IRCCS Ospedale Policlinico San Martino 16132 Genoa Italy
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc24007821
- 003
- CZ-PrNML
- 005
- 20240423160310.0
- 007
- ta
- 008
- 240412e20231013fr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.biochi.2023.09.026 $2 doi
- 035 __
- $a (PubMed)37838351
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Vojsovič, Matúš $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkyňova 118, 61200, Brno, Czech Republic. Electronic address: matusvojovic98@gmail.com
- 245 10
- $a Transactivation by partial function P53 family mutants is increased by the presence of G-quadruplexes at a promoter site / $c M. Vojsovič, L. Kratochvilová, N. Valková, L. Šislerová, Z. El Rashed, P. Menichini, A. Inga, P. Monti, V. Brázda
- 520 9_
- $a The effect of mutations in the P53 family of transcription factors on their biological functions, including partial or complete loss of transcriptional activity, has been confirmed several times. At present, P53 family proteins showing partial loss of activity appear to be promising potential candidates for the development of novel therapeutic strategies which could restore their transcriptional activity. In this context, it is important to employ tools to precisely monitor their activity; in relation to this, non-canonical DNA secondary structures in promoters including G-quadruplexes (G4s) were shown to influence the activity of transcription factors. Here, we used a defined yeast assay to evaluate the impact of differently modeled G4 forming sequences on a panel of partial function P53 family mutant proteins. Specifically, a 22-mer G4 prone sequence (derived from the KSHV virus) and five derivatives that progressively mutate characteristic guanine stretches were placed upstream of a minimal promoter, adjacent to a P53 response element in otherwise isogenic yeast luciferase reporter strains. The transactivation ability of cancer-associated P53 (TA-P53α: A161T, R213L, N235S, V272L, R282W, R283C, R337C, R337H, and G360V) or Ectodermal Dyplasia syndromes-related P63 mutant proteins (ΔN-P63α: G134D, G134V and inR155) were tested. Our results show that the presence of G4 forming sequences can increase the transactivation ability of partial function P53 family proteins. These observations are pointing to the importance of DNA structural characteristics for accurate classification of P53 family proteins functionality in the context of the wide variety of TP53 and TP63 germline and somatic mutations.
- 650 12
- $a nádorový supresorový protein p53 $x metabolismus $7 D016159
- 650 _2
- $a aktivace transkripce $7 D015533
- 650 _2
- $a Saccharomyces cerevisiae $x genetika $x metabolismus $7 D012441
- 650 12
- $a G-kvadruplexy $7 D054856
- 650 _2
- $a transkripční faktory $x metabolismus $7 D014157
- 650 _2
- $a DNA $x chemie $7 D004247
- 650 _2
- $a mutantní proteiny $x genetika $7 D050505
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Kratochvilová, Libuše $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkyňova 118, 61200, Brno, Czech Republic. Electronic address: kratochvilova@ibp.cz
- 700 1_
- $a Valková, Natália $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic. Electronic address: nataliabohalova@gmail.com
- 700 1_
- $a Šislerová, Lucie $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkyňova 118, 61200, Brno, Czech Republic. Electronic address: l.sislerova@ibp.cz
- 700 1_
- $a El Rashed, Zeinab $u Gene Expression Regulation, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. Electronic address: zeinab.elrashed@hsanmartino.it
- 700 1_
- $a Menichini, Paola $u Mutagenesis and Cancer Prevention, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. Electronic address: paola.menichini@hsanmartino.it
- 700 1_
- $a Inga, Alberto $u Laboratory of Transcriptional Networks, Department of Cellular, Computational and Integrative Biology, CIBIO, University of Trento, Via Sommarive 9, 38123, Trento, Italy. Electronic address: alberto.inga@unitn.it
- 700 1_
- $a Monti, Paola $u Mutagenesis and Cancer Prevention, IRCCS Ospedale Policlinico San Martino, 16132, Genoa, Italy. Electronic address: paola.monti@hsanmartino.it
- 700 1_
- $a Brázda, Václav $u Institute of Biophysics of the Czech Academy of Sciences, Královopolská 135, 61200, Brno, Czech Republic; Department of Food Chemistry and Biotechnology, Faculty of Chemistry, Brno University of Technology, Purkyňova 118, 61200, Brno, Czech Republic. Electronic address: vaclav@ibp.cz
- 773 0_
- $w MED00009325 $t Biochimie $x 1638-6183 $g Roč. 216 (20231013), s. 14-23
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/37838351 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20240412 $b ABA008
- 991 __
- $a 20240423160306 $b ABA008
- 999 __
- $a ok $b bmc $g 2081676 $s 1217588
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2024 $b 216 $c - $d 14-23 $e 20231013 $i 1638-6183 $m Biochimie $n Biochimie $x MED00009325
- LZP __
- $a Pubmed-20240412